Helping prostate cancer patients with localized disease reach treatment decisions
Sunday, February 28th, 2010 Posted in prostate cancer | No Comments »A recent sudy at Tom Baker Cancer Center, Psychosocial Resources, 2202 2nd St SW, Calgary, Canada, aimed to highlight two important aspects: role of psychosocial variables in treatment decision making for patients with localized prostate cancer, and how family physicians can be ...
Patient misperceptions about treatment choices for localized prostate cancer
Saturday, February 27th, 2010 Posted in prostate cancer | No Comments »Researchers at Eastern Virginia Medical School, USA, suggest that higher education, income and functional capacity of cancer patients are associated with poorer knowledge about their cancer, poorer understanding about treatment choices, and poorer judgement about survival with and without treatment ...
New way to treat castrate resistant cells in prostate cancer patients
Friday, February 26th, 2010 Posted in hormone therapy | No Comments »Biomedical scientists Monash University, Australia, have identified a new way to treat castrate resistant cells in prostate cancer sufferers. For more than 60 years the main way to treat the most common cancer in Australian men has involved removing the hormones ...
Focal therapy may be the future for prostate cancer
Thursday, February 25th, 2010 Posted in prostate cancer | No Comments »A scientific team at University College London, UK, has now published an article outlining the need for an international research strategy which could be used to evaluate focal therapy over time. According to which should be "pragmatic" in nature and ...
Statins may benefit prostate cancer patients
Wednesday, February 24th, 2010 Posted in prostate cancer | No Comments »Duke University Medical Center researchers found cholesterol-lowering statins significantly reduce prostate tumor inflammation. This new study suggests this finding may help lower the risk of disease progression Researchers concluded that the use of statins before prostate cancer surgery was associated with ...
Surgeon skills more important than type of surgery
Tuesday, February 23rd, 2010 Posted in prostatectomy | No Comments »A recent analysis of the outcomes of different types of radical prostatectomy appears to reveal no difference between the patients’ clinical outcomes following laparoscopic (including non-robot-assisted and robot-assisted) categories of surgery (LRP/RALP) and traditional “open” radical retropubic prostatectomy (RRP) when ...
Comparison study of open and laparoscopic surgery found few differences in outcome
Monday, February 22nd, 2010 Posted in prostatectomy | No Comments »A new study at Memorial Sloan-Kettering Cancer Center in New York City compared open radical prostatectomy (ORP) and laparoscopic radical prostatectomy (LRP), outcames in nearly 6,000 men, age 66 or older, with localized prostate cancer. Currently, open radical prostatectomy (ORP) is ...
Effect of extended vs standard pelvic lymphadenectomy
Saturday, February 20th, 2010 Posted in prostate cancer | No Comments »A recent study at The Royal Surrey County Hospital, Guildford, UK, investigated the effect of extended vs standard pelvic lymphadenectomy (sPLND) for patients with intermediate- and high-risk prostate cancer undergoing laparoscopic radical prostatectomy (LRP). Study team has published data from their ...
Abiraterone drug shows promise for advanced prostate cancer
Friday, February 19th, 2010 Posted in prostate cancer | No Comments »Recent results related to a phase II clinical trial of the prostate cancer drug abiraterone confirm that it may help men with advanced disease who have tried standard treatments. According to research team, new drug shows promise for advanced prostate cancer ...
Researchers discover new prognosis marker for prostate cancer
Thursday, February 18th, 2010 Posted in prostate cancer diagnosis | No Comments »Thinking related to today's prognosis markers, one of the critical problems with prostate cancer is that about 70-80 percent of patients wind up in a group where very little can be said about their prognosis. Unfortunately, there are no methods ...